XNCR Q2 2017 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M-79.8% YoY

Gross Profit

-$4M-26.8% margin

Operating Income

-$8M-57.5% margin

Net Income

-$7M-51.6% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+207.4%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$416M

Total Liabilities

$115M

Stockholders' Equity

$301M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$66M	-79.8%
Gross Profit	-$4M	$52M	-106.9%
Operating Income	-$8M	$49M	-115.8%
Net Income	-$7M	$47M	-114.6%